Vuno KRX:338220KOSDAQ
뷰노 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days22
DART filings, 7 days1
Articles tracked105since Sep 11
In Q2 2026, Vuno reported revenue of ₩6.1bn, down 34.0% year on year, and an operating loss of ₩4.2bn. Vuno (뷰노) appeared in 22 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 20 with 11 articles. The most common catalyst was tech & capacity (3). It was most often mentioned alongside Lunit, Neurophet and Noul.
Vuno quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩6.1bn | -34.0% | −₩4.2bn margin −68.9% | −₩5.4bn |
| Q1 2026 | ₩6.0bn | -19.7% | −₩4.1bn margin −67.9% | −₩4.0bn |
| Q4 2025 derived | ₩7.2bn | +2.2% | −₩2.4bn margin −32.5% | −₩2.7bn |
| Q3 2025 | ₩10.8bn | +57.7% | ₩1.0bn margin 9.4% | ₩1.0bn |
| Q2 2025 | ₩9.3bn | +44.8% | −₩169m margin −1.8% | −₩817m |
| Q1 2025 | ₩7.5bn | +36.1% | −₩3.4bn margin −45.5% | −₩3.3bn |
| Q4 2024 derived | ₩7.1bn | +43.6% | −₩2.7bn margin −37.8% | −₩3.1bn |
| Q3 2024 | ₩6.9bn | +92.4% | −₩2.8bn margin −40.3% | −₩2.8bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Vuno top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest Vuno news Korean headlines
-
루닛이 끌어올린 의료AI…뷰노 평가·뉴로핏 빅파마 계약 주목[바이오맥짚기]
1 more on this story · 1 outlets
- 루닛이 끌어올린 의료AI…뷰노 평가·뉴로핏 빅파마 계약 주목[바이오맥짚기]이데일리 · Oct 28 07:01
-
뷰노, KIMES 부산서 셀프 심전도 선봬
1 more on this story · 1 outlets
- 뷰노, KIMES 부산서 셀프 심전도 측정기 ‘하티브’ 체험존 운영더바이오 · Oct 23 16:55
-
뷰노, ‘RCT 설계’ 국제논문 게재
1 more on this story · 1 outlets
- 뷰노, 딥카스 무작위 임상연구 설계 국제논문 게재메디포뉴스 · Oct 20 12:30